On Tuesday, Orbitz Worldwide, Inc. (NYSE:OWW)’s shares declined -2.00% to $10.80.
Orbitz Worldwide, Inc. (OWW) has partnered with its home state Illinois Office of Tourism to launch “Orbitz Originals: Illinois,” a seven-part online video series hosted by award-winning travel expert Richard Bangs. The series is accessible for viewing on the all-new Orbitz Travel Guides app on Amazon Fire TV & Fire TV Stick in addition to Orbitz.com/Illinois. Supported by hotel discounts of up to 20 percent and substantial flight and hotel package savings, this thirteenth installment of the “Orbitz Originals” series once again uses the power of online video to inspire travelers and enhance bookings to one of the premier states of America’s heartland.
Orbitz Worldwide, Inc. operates as an online travel company worldwide. It uses technology that enables leisure and business travelers to research, plan, and book a range of travel products and services, counting hotels, flights, vacation packages, car rentals, rail tickets, cruises, travel insurance, destination, services and event tickets. It also provides various travel administration services; and private label travel solutions to a range of partners. The companys brand portfolio comprises Orbitz and CheapTickets in the United States; ebookers in Europe; and HotelClub in the Asia Pacific, in addition to RatesToGo. Orbitz Worldwide, Inc. was founded in 2000 and is headquartered in Chicago, Illinois.
Intrexon Corp (NYSE:XON)’s shares gained 11.05% to $60.60.
Intrexon Corporation (XON) declared that it has reached a partnership with an investment fund sponsored by Harvest Capital Strategies, LLC. The fund is believed to be the world’s first that is dedicated to the inventions and discoveries of a single company.
Intrexon has agreed to provide the fund a noteworthy number of investment proposals from across five sectors – Health, Energy, Food, Environment and Consumer – that are suitable for pursuit by a startup, counting several in 2015. With respect to such proposals, Intrexon will provide the fund with exclusive rights of first-look and first negotiation. Intrexon presently sees the potential to form up to ten new companies per year, each of which will have access to Intrexon’s proprietary technology platform through an Exclusive Channel Collaboration. Although the partnership with the fund will be complimentary to programs already underway at Intrexon, nothing in the arrangement will limit the Company’s ability to execute other collaborations and joint ventures.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components. Its technologies comprise UltraVector gene design and fabrication platform, and its associated library of modular DNA components; cell systems informatics; RheoSwitch inducible gene switch; AttSite Recombinases; protein engineering; mAbLogix; and laser-enabled analysis and processing. Intrexon Corporation has partnership agreements with ZIOPHARM Oncology, Inc.; Synthetic Biologics, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; AquaBounty Technologies, Inc.; S & I Ophthalmic, LLC; Biological & Popular Culture, Inc.; OvaXon, LLC; Intrexon Energy Partners, LLC; and Persea Bio, LLC; and planned partnershipand licensing agreement with Merck Serono S.A. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
At the end of Tuesday’s trade, Take-Two Interactive Software, Inc. (NASDAQ:TTWO)‘s shares surged 2.57% to $31.52.
Take-Two Interactive Software, Inc. (TTWO) declared that it plans to report financial results for the first quarter of its fiscal year 2016, ended June 30, 2015, after the market close on Monday, August 10, 2015. The Company plans to hold a conference call to talk about its results at 4:30 p.m. Eastern Time, which can be accessed by dialing (877) 407-0984 or (201) 689-8577.
Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels; offering downloadable episodes, and content and currency; and releasing titles for smartphones and tablets.
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), shares showed no change and closed at $14.20.
Allscripts (MDRX) client Atlantic General Hospital, located in Berlin, Maryland, U.S.A., achieved Stage 6 on the HIMSS Analytics EMR Adoption ModelSM (EMRAM) using the Allscripts Sunrise acute electronic health record (EHR).
The HIMSS Analytics EMR Adoption Model measures progress and the cumulative capabilities of EMR systems within hospitals. There are eight stages (0-7) in the HIMSS Analytics EMR Adoption Model, and 17.9% of hospitals in the HIMSS Analytics(R) Database have currently reached Stage 6. Hospitals that reach Stage 6 have established clear goals for improving safety, minimizing errors, and prioritizing IT implementations.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions segment provides integrated clinical software applications, financial and information solutions, and related installation and maintenance services, counting EHR related software, financial and practice administration software, related installation and training services, and electronic claims administration services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
